Cantor Fitzgerald raised the firm’s price target on Lemonade (LMND) to $92 from $85 and keeps an Overweight rating on the shares. The initial positive stance on insurance brokers appears premature and overly optimistic, as near-term fundamentals are likely to deteriorate before improving. While the subgroup remains interesting, negative consensus organic growth revisions are expected in the interim.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LMND:
- AI Adoption Could Lift These 2 Stocks Higher, Says Truist
- Lemonade initiated with a Buy at Truist
- Lemonade Stock Slides as Hot Rally Faces Reality
- Lemonade Stock Heats Up as Wall Street Warms
- Lemonade call volume above normal and directionally bullish
